CymaBay Therapeutics, Inc. CBAY
32.48 +32.48
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 31.07M | 0 | 0 | 0 | 0 | |
| 31.07M | 0 | 0 | 0 | 0 | |
| -101.68M | -93.11M | -87.58M | -52.60M | -108.15M | |
| -105.37M | -106.00M | -90.00M | -50.99M | -102.81M | |
| -0.99 | -1.21 | -1.27 | -0.74 | -1.53 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 206.53M | 20.29M | 125.81M | 28.19M | 24.87M | |
| 434.69M | 141.85M | 202.32M | 153.82M | 205.73M | |
| 142.43M | 105.70M | 69.38M | 11.12M | 19.38M | |
| 114.49M | 90.26M | 51.02M | 1.26M | 1.74M | |
| 292.26M | 36.15M | 132.94M | 142.71M | 186.35M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -72.53M | -84.08M | -69.43M | -44.73M | -97.91M | |
| -86.57M | -45.98M | 48.59M | 47.96M | -34.35M | |
| 345.77M | 24.55M | 118.45M | 92.00K | 108.13M | |
| -445.00K | -148.00K | -87.00K | -21.00K | -315.00K | |
| 186.67M | -105.52M | 97.61M | 3.32M | -24.13M |